Elisa Araldi

3.7k total citations
33 papers, 2.8k citations indexed

About

Elisa Araldi is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Elisa Araldi has authored 33 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Elisa Araldi's work include MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (11 papers) and Circular RNAs in diseases (10 papers). Elisa Araldi is often cited by papers focused on MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (11 papers) and Circular RNAs in diseases (10 papers). Elisa Araldi collaborates with scholars based in United States, Spain and Germany. Elisa Araldi's co-authors include Yajaira Suárez, Carlos Fernández‐Hernando, Aránzazu Chamorro‐Jorganes, Ernestina Schipani, Noemí Rotllán, Cristina M. Ramírez, Alberto Canfrán‐Duque, Leigh Goedeke, Amato J. Giaccia and Richa Khatri and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Elisa Araldi

32 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Araldi United States 28 1.7k 1.4k 390 362 248 33 2.8k
Zheng Zhang China 29 1.5k 0.9× 762 0.6× 518 1.3× 315 0.9× 669 2.7× 128 3.0k
Zhiyong Lin United States 26 2.4k 1.4× 584 0.4× 529 1.4× 352 1.0× 301 1.2× 51 3.4k
Xinghui Sun United States 25 1.7k 1.0× 1.4k 1.0× 592 1.5× 209 0.6× 81 0.3× 51 2.8k
Thomas Hellwig‐Bürgel Germany 17 1.1k 0.6× 1.4k 1.0× 321 0.8× 167 0.5× 222 0.9× 24 2.4k
Elisabeth Deindl Germany 30 1.6k 0.9× 441 0.3× 422 1.1× 526 1.5× 137 0.6× 87 2.7k
Ganapati H. Mahabeleshwar United States 31 2.1k 1.3× 768 0.6× 998 2.6× 189 0.5× 215 0.9× 46 3.5k
Fengjun Xiao China 30 1.6k 0.9× 817 0.6× 344 0.9× 264 0.7× 141 0.6× 101 2.7k
Sébastien P. Tabruyn Belgium 26 1.3k 0.8× 767 0.6× 276 0.7× 286 0.8× 154 0.6× 36 2.4k
Zhongwei Cao China 26 1.6k 0.9× 713 0.5× 326 0.8× 610 1.7× 114 0.5× 43 3.0k
Katarzyna Miękus Poland 19 1.8k 1.1× 999 0.7× 443 1.1× 228 0.6× 131 0.5× 37 2.7k

Countries citing papers authored by Elisa Araldi

Since Specialization
Citations

This map shows the geographic impact of Elisa Araldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Araldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Araldi more than expected).

Fields of papers citing papers by Elisa Araldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Araldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Araldi. The network helps show where Elisa Araldi may publish in the future.

Co-authorship network of co-authors of Elisa Araldi

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Araldi. A scholar is included among the top collaborators of Elisa Araldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Araldi. Elisa Araldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauer, Katrin, Raissa Lerner, Thomas Koeck, et al.. (2025). Effect of Empagliflozin on the plasma lipidome in patients with type 2 diabetes mellitus: results from the EmDia clinical trial. Cardiovascular Diabetology. 24(1). 359–359.
2.
Zhang, Xinbo, Jeffrey G. McDonald, Binod Aryal, et al.. (2021). Desmosterol suppresses macrophage inflammasome activation and protects against vascular inflammation and atherosclerosis. Proceedings of the National Academy of Sciences. 118(47). 85 indexed citations
3.
Kobiita, Ahmad, Elisa Araldi, Umesh Ghoshdastider, et al.. (2020). The Diabetes Gene JAZF1 Is Essential for the Homeostatic Control of Ribosome Biogenesis and Function in Metabolic Stress. Cell Reports. 32(1). 107846–107846. 36 indexed citations
4.
Price, Nathan L., Abhishek K. Singh, Noemí Rotllán, et al.. (2018). Genetic Ablation of miR-33 Increases Food Intake, Enhances Adipose Tissue Expansion, and Promotes Obesity and Insulin Resistance. Cell Reports. 22(8). 2133–2145. 90 indexed citations
5.
Araldi, Elisa, Marta Fernández‐Fuertes, Alberto Canfrán‐Duque, et al.. (2017). Lanosterol Modulates TLR4-Mediated Innate Immune Responses in Macrophages. Cell Reports. 19(13). 2743–2755. 76 indexed citations
6.
Canfrán‐Duque, Alberto, Noemí Rotllán, Xinbo Zhang, et al.. (2017). Macrophage deficiency of miR‐21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis. EMBO Molecular Medicine. 9(9). 1244–1262. 154 indexed citations
7.
Ulrich, Victoria, Noemí Rotllán, Elisa Araldi, et al.. (2016). Chronic miR‐29 antagonism promotes favorable plaque remodeling in atherosclerotic mice. EMBO Molecular Medicine. 8(6). 643–653. 61 indexed citations
8.
Araldi, Elisa & Yajaira Suárez. (2016). MicroRNAs as regulators of endothelial cell functions in cardiometabolic diseases. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(12). 2094–2103. 43 indexed citations
9.
Aryal, Binod, Noemí Rotllán, Elisa Araldi, et al.. (2016). ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression. Nature Communications. 7(1). 12313–12313. 79 indexed citations
10.
Mangiavini, Laura, Christophe Merceron, Elisa Araldi, et al.. (2015). Fibrosis and Hypoxia-Inducible Factor-1α–Dependent Tumors of the Soft Tissue on Loss of Von Hippel-Lindau in Mesenchymal Progenitors. American Journal Of Pathology. 185(11). 3090–3101. 8 indexed citations
11.
Goedeke, Leigh, Noemí Rotllán, Alberto Canfrán‐Duque, et al.. (2015). MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels. Nature Medicine. 21(11). 1280–1289. 211 indexed citations
12.
Goedeke, Leigh, Noemí Rotllán, Cristina M. Ramírez, et al.. (2015). miR-27b inhibits LDLR and ABCA1 expression but does not influence plasma and hepatic lipid levels in mice. Atherosclerosis. 243(2). 499–509. 56 indexed citations
13.
Mangiavini, Laura, Christophe Merceron, Elisa Araldi, et al.. (2014). Loss of VHL in mesenchymal progenitors of the limb bud alters multiple steps of endochondral bone development. Developmental Biology. 393(1). 124–136. 27 indexed citations
14.
Chamorro‐Jorganes, Aránzazu, Elisa Araldi, Noemí Rotllán, Daniel Cirera‐Salinas, & Yajaira Suárez. (2014). Autoregulation of glypican-1 by intronic microRNA-149 fine-tunes the angiogenic response to fibroblast growth factor in human endothelial cells. Journal of Cell Science. 127(Pt 6). 1169–78. 56 indexed citations
15.
Miller, Ashley M., Derek S. Gilchrist, Jagtar Singh Nijjar, et al.. (2013). MiR-155 Has a Protective Role in the Development of Non-Alcoholic Hepatosteatosis in Mice. PLoS ONE. 8(8). e72324–e72324. 98 indexed citations
16.
Chamorro‐Jorganes, Aránzazu, Elisa Araldi, & Yajaira Suárez. (2013). MicroRNAs as pharmacological targets in endothelial cell function and dysfunction. Pharmacological Research. 75. 15–27. 86 indexed citations
17.
Rankin, Erinn B., Colleen Wu, Richa Khatri, et al.. (2012). The HIF Signaling Pathway in Osteoblasts Directly Modulates Erythropoiesis through the Production of EPO. Cell. 149(1). 63–74. 222 indexed citations
18.
Araldi, Elisa, Eva‐Maria Krämer‐Albers, Héctor Peinado, et al.. (2012). International Society for Extracellular Vesicles: first annual meeting, April 17–21, 2012: ISEV‐2012. Journal of Extracellular Vesicles. 1(1). 19995–19995. 28 indexed citations
19.
Klinakis, Apostolos, Camille Lobry, Omar Abdel‐Wahab, et al.. (2011). A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature. 473(7346). 230–233. 271 indexed citations
20.
Araldi, Elisa & Ernestina Schipani. (2010). Hypoxia, HIFs and bone development. Bone. 47(2). 190–196. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zheng Zhang Breakdown of academic impact, for papers by Zhiyong Lin Breakdown of academic impact, for papers by Xinghui Sun Breakdown of academic impact, for papers by Thomas Hellwig‐Bürgel Breakdown of academic impact, for papers by Elisabeth Deindl Breakdown of academic impact, for papers by Ganapati H. Mahabeleshwar Breakdown of academic impact, for papers by Fengjun Xiao Breakdown of academic impact, for papers by Sébastien P. Tabruyn Breakdown of academic impact, for papers by Zhongwei Cao Breakdown of academic impact, for papers by Katarzyna Miękus
Rankless by CCL
2026